Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach

Health Economics Review · Published 2026-07-15 · DOI 10.1186/s13561-026-00817-w

Free full text

Authors (31)

Said Wani, Hilal Alsabti, Said Allamki, Ahmed Almandhari, Suleiman Alhajji, Ibrahim Alrashdi, Raid Alsabri, Adnan Alqassabi, Ahmed Alzaabi, Aisha Almaashani, Alia Alshuaili, Anisa Rasool, Asiya Alkindi, Bushra Salman, Faiza Alzadjali, Khalid Alrahbi, Khulood Almutawa, Manal Alansari, Mardheya Alkharusi, Nadiya Albulushi, Rahma Alghadani, Rana Aljaber, Safiya Almuaini, Said Alkindi, Salim Alzawamri, Sara Albalushi, Suha Allawati, Zuhair Alsalti, Hassan Albalushi, Ahmad Nader Fasseeh, Zoltan Kalo

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wani, S., Alsabti, H., Allamki, S., et al. (2026). Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach. Health Economics Review. https://doi.org/10.1186/s13561-026-00817-w

Related articles

• Does long-term care insurance promote assistive device utilization? Evidence from pilot regions in China · Health Economics Review · 2026 · Same journal
• Cost-effectiveness of AI-enhanced breast cancer screening in Iran: a microsimulation study · Health Economics Review · 2026 · Same journal
• Rapid socio-economic evaluation of hospital construction projects based on counterfactual theory: the regional planning perspective · Health Economics Review · 2026 · Same journal
• Heterogeneous impact of health insurance on children’s nutritional status: insights from Instrumental Variable Quantile Regression (IV-QR) approach · Health Economics Review · 2026 · Same journal
• Provider behavior from FFS to DRGs payment: experimental evidence from real physicians · Health Economics Review · 2026 · Same journal
• Sacituzumab govitecan plus pembrolizumab for advanced triple-negative breast cancer with PD-L1-positive: a cost-effectiveness analysis · Health Economics Review · 2026 · Same journal
• Environmental regulation and industrial restructuring: choices of health industry enterprises in China · Health Economics Review · 2026 · Same journal
• Health IT vendor concentration and the dynamics of hospital costs: evidence from California hospitals · Health Economics Review · 2026 · Same journal
• The cost-effectiveness of telestroke in the treatment of acute ischemic stroke in China · Health Economics Review · 2026 · Same journal
• Who wants to pay more taxes for better long-term care services: evidence from OECD surveys · Health Economics Review · 2026 · Same journal